Skip to content

Evaluation of the effect of buccal acupuncture in perioperative multi-mode analgesia of total knee arthroplasty

Evaluation of the effect of buccal acupuncture in perioperative multi-mode analgesia of total knee arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001616
Enrollment
Unknown
Registered
2026-06-26
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Pain and Postoperative Recovery

Interventions

Facial acupuncture group:Cheek acupuncture stimulation at the knee point, hip point, and knee point auxiliary point, with needles retained for 30 minutes.
Control Group:No buccal needle therapy will be administered
routine perioperative management will be carried out.

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Age = 18 years 2) ASA I-III grade; 3) Scheduled to undergo elective robot-assisted unilateral knee arthroplasty under general anesthesia, first-time surgery, and meet the indications for surgery; 4) Signed written informed consent, able to understand the purpose of the study, intervention plan, and potential risks, and agree to comply with the study protocol.

Exclusion criteria

Exclusion criteria: 1) Drug allergy or contraindications: The patient has allergic reactions or contraindications to drugs used in the study (e.g., local anesthetics, opioids, glucocorticoids, etc.); 2) Opioid dependence or abuse: History of long-term use of opioids, or presence of opioid dependence or abuse; 3) Severe systemic diseases: The patient has severe systemic diseases, such as: a) Severe cardiovascular diseases (e.g., acute coronary syndrome, heart failure, NYHA heart function = Class 3, etc.); b) Uncontrolled hypertension (systolic blood pressure = 180 mmHg or diastolic blood pressure = 110 mmHg); c) Severe diabetes (fasting blood glucose = 180 mg/dL or HbA1c = 10%); d) Severe liver or kidney dysfunction; e) Neurological or psychiatric diseases: History of mental disorders (e.g., major depressive disorder, schizophrenia, etc.) or cognitive impairment; f) Smoking and alcohol consumption: Smoking more than 20 cigarettes per day in the past five years, or history of alcohol abuse (daily alcohol intake = 40g); g) Preoperative weight abnormalities: Body Mass Index (BMI) 30 kg/m²; (2) Surgical complexity: Patients with a high risk of complications during surgery (e.g., surgery duration exceeding 5 hours); (3) Already enrolled in other studies.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale during exercise;

Secondary

MeasureTime frame
Intraoperative opioid (fentanyl) dosage;Visual Analogue Scale during exercise;Visual Analogue Scale at rest;Shear modulus of the quadriceps femoris (rectus femoris, vastus lateralis, vastus medialis) on the surgical side;Functional muscle strength of the quadriceps femoris on the surgical side.;IL-6 levels in plasma;Plasma IL-10 level;The levels of TNF-a in plasma;Number of intraoperative hemodynamic events;Post-anesthesia recovery score (Aldrete score);Dosage of rescue analgesics;Postoperative nausea and vomiting occurrence;Postoperative delirium occurrence;Patient Satisfaction Score;Postoperative hospital stay duration;Post Anesthesia Care Unit stay time;

Countries

China

Contacts

Public ContactLiu Xiaowen

China-Japan Friendship Hospital

liuxiaowen@Outlook.com13261801669

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026